Yes, THCA is legally treated as a controlled substance in Israel under the 1988 Dangerous Drugs Ordinance, despite its non-psychoactive precursor status. The Israel Anti-Drug Authority (IADA) classifies THCA as a “cannabinoid derivative” subject to the same restrictions as THC, requiring import/export licenses from the Ministry of Health’s Medical Cannabis Unit. Recent 2026 amendments to the Pharmaceuticals Ordinance further tighten oversight, mandating THCA-containing products to meet pharmaceutical-grade purity standards for any medical use.
Key Regulations for THCA in Israel
- Controlled Substance Classification: THCA is explicitly listed under Schedule I of the Dangerous Drugs Ordinance, prohibiting recreational use without a medical prescription. The IADA enforces this via periodic inspections of licensed cannabis facilities.
- Medical Use Authorization: Only THCA products approved by the Ministry of Health’s Medical Cannabis Unit may be prescribed, with strict dosage and labeling requirements. Unapproved products face immediate confiscation under the Pharmaceuticals Ordinance.
- Import/Export Licensing: Entities handling THCA must secure permits from the Ministry of Health, which verifies compliance with Good Manufacturing Practices (GMP) and THC content thresholds (<0.3% for exemptions). Violations trigger penalties under the Customs Ordinance.